Archives: Speakers

Ros Cheetham is Vice President, Clinical Operations, at MacroGenics. Immediately prior to joining MacroGenics, Ms Cheetham was Senior Vice President, Clinical Solutions and Strategic Partnerships at the WIRB Copernicus Group.

Prior to these roles, Ms Cheetham spent several years as a consultant to the Biotech industry following a varied career within the pharmaceutical industry. Those industry roles included Vice President of Global Clinical Operations at Allergan; several leadership positions at GSK, including Vice President and Medicines Development Leader in both Neurosciences and Rare Diseases, as well as other leadership positions within global clinical operations. Earlier in her career she worked for Janssen Pharmaceutica in the US, Belgium and South Africa and had a pivotal role in the global development and registration of the novel antipsychotic, risperidone (Risperdal®).

Throughout her career, Ms Cheetham has taken a keen interest in how to improve trial outcomes and success including enhancing diversity in clinical trials. She has advised Biotech companies on their DEI strategies and has successfully led the creation of FDA Diversity plans.

Ms Cheetham obtained her undergraduate degree at Imperial College, London and her Master’s degree at the University of the Witwatersrand, Johannesburg.

Rich has over 25 years of CMC Regulatory Affairs with positions of increasing responsibility with GSK, PDL Biopharma, Wyeth Pharmaceuticals and currently with Pfizer, Inc as a senior director for vaccines CMC regulatory affairs.  Rich currently leads a team of 30 CMC Regulatory professionals responsible for supporting the development and production of various vaccines for the prevention of Sars-CoV-2 (Covid 19), C. Difficile, RSV, Group B Streptococcus, and Influenza.  Since the beginning of the pandemic, he has been one of the global leaders responsible for developing the BioNtech/Pfizer mRNA Covid-19 Vaccine.  Rich has been responsible for CMC Regulatory leadership on various vaccine programs over the last 25 years including the Prevnar 13 Vaccine global market submissions and approvals, coral snake antivenin production restart as well as various development programs including Staphylococcus aureus and RSV.

Rich has been an educator and guest speaker at various industry seminars and forums including The World Vaccine Congress, The American Association of Pharmaceutical Scientists National Biotechnology Conference, The International Society for Bioprocess Technology Nucleic Acids Conference, CASSS WCBP Conference, Academy for Institutional Investors Investment Forums, IBC Life Sciences programs, Regulatory Affairs Professional Society, and several other educational organizations.  Rich is also the Author of CMC Regulatory Affairs 101:  What does CMC Regulatory Affairs Do? (American Pharmaceutical Outsourcing:  Nov./Dec. 2007), and a contributing reviewer for the 5^th edition of Fundamentals of US Regulatory Affairs (Chapter 15 on Biologics submission 2007) for the Regulatory Affairs Professionals Society.

Rich received a Bachelor of Science degree in Chemical Engineering from NC State University.  Rich is a 7-Time Ironman Triathlon finisher and was a division one swimmer for NC State University.  When Rich is not working on vaccine development, he enjoys playing golf and spending quality time at the beach in Oak Island, NC with his family.

• Dr Gerd Wedler, PhD in Solid State Physics
• 20 years experience in the industry innovation & engineering (Infineon, VDI VDE IT, AOA, Diehl, …)
• Since 2010 responsible for systems engineering and fire protection of rolling stock at Diehl (formerly AOA)
• Currently expanding Diehl’s 20 years of FP experience to full system integration in rolling stock (detection, extinguishing, system integration & certification).

• 56 years old
• CH and AT citizenship
• Since 2007 with WAGNER
• Managing director of Wagner Rail activity globally
• More than 30 years experience in fire protection
• Representant of Switzerland in many European (CEN) and international (ISO) expert committees for fire protection such as gas extinguishing Aerosol extinguishing or water mist, latest on fire protection on Li-Ion batteries
• PhD degree in Mechanical Engineering and Master degree in Business Administration

Markus Müller (56), Managing Director of Wagner Rail, holds a PhD in mechanical engineering and an MBA from the Universities in Zurich (ETH) and St. Gallen (HSG). He has more than 30 years of experience in fire protection and joined WAGNER in 2007 after working for Cerberus and Siemens in Switzerland and France. As Managing Director of Wagner Rail he is leading the rolling stock fire protection of Wagner Group globally, and represents Switzerland in international expert committees for fire protection solutions.